You are here

  • Home
  • Archive
  • Volume 79, Issue 11
  • Methotrexate reduces withdrawal rates of TNF inhibitors due to ineffectiveness in rheumatoid arthritis but only in patients who are seropositive

Article metrics

Article menu
Download PDFPDF
Letter
Methotrexate reduces withdrawal rates of TNF inhibitors due to ineffectiveness in rheumatoid arthritis but only in patients who are seropositive

 

Online download statistics by month:

Online download statistics by month: May 2020 to April 2025

AbstractFullPdf
May 20204673314
Jun 20207416950
Jul 2020252127
Aug 2020115189
Sep 20206644
Oct 20205305533
Nov 20202804527
Dec 20201452927
Jan 20212235336
Feb 2021184107
Mar 20217275
Apr 202163106
May 20212751
Jun 202114117
Jul 20211183
Aug 20211124
Sep 20211031
Oct 20216152
Nov 20214221
Dec 202111031
Jan 20225020
Feb 20229854
Mar 20228495
Apr 20226912
May 20228152
Jun 20225910
Jul 20223611
Aug 20228110
Sep 20228431
Oct 20225320
Nov 20227840
Dec 20223521
Jan 20237850
Feb 202311110
Mar 20236821
Apr 20236320
May 20235801
Jun 20236443
Jul 20236711
Aug 20238111
Sep 202353103
Oct 202375104
Nov 2023108185
Dec 20237582
Jan 20243656
Feb 202416433
Mar 202411961
Apr 202410032
May 20244710
Jun 20242311
Jul 20247711
Aug 202471101
Sep 20245665
Oct 20247043
Nov 20248731
Dec 20246623
Jan 202511410
Feb 20251820
Mar 2025440
Apr 2025960
Total6194540309